(Q45941142)

18 December 2017

title

Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers. (English)

1 reference

18 December 2017

1 reference

1 reference

Yi Wang

1

1 reference

18 December 2017

Jiang Cao

series ordinal

2

1 reference

18 December 2017

Xiaodan Wang

series ordinal

3

1 reference

18 December 2017

Su Zeng

series ordinal

4

1 reference

18 December 2017

publication date

1 March 2010

1 reference

18 December 2017

published in

Chirality

1 reference

18 December 2017

volume

22

1 reference

18 December 2017

page(s)

361-368

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

Studies of the absorption and removal of propranolol in hypertensive patients during therapy

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

Stereoselective binding of propranolol in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

Optical Isomers of Propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Stereoselective disposition and glucuronidation of propranolol in humans

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Plasma concentrations of propranolol in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Enantioselective metabolism of propanolol in isolated hepatocytes prepared from untreated, PB- or 3-MC-pretreated rats

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Chiral reversed phase high-performance liquid chromatography for determining propranolol enantiomers in transgenic Chinese hamster CHL cell lines expressing human cytochrome P450.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Caco-2 cell permeability assays to measure drug absorption.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Transport characteristics of fexofenadine in the Caco-2 cell model

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human breast cancer cells, by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Characteristics of ceftibuten uptake into Caco-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Guanidine transport across the apical and basolateral membranes of human intestinal Caco-2 cells is mediated by two different mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Species differences in stereoselective hydrolase activity in intestinal mucosa

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Variability in Caco-2 and MDCK cell-based intestinal permeability assays

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Stereospecific absorption and degradation of cephalexin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Carrier-mediated intestinal transport of drugs

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Stereoselectivity of the reduced folate carrier in Caco-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Subcellular proteomics of cell differentiation: Quantitative analysis of the plasma membrane proteome of Caco-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20753

7 January 2021

Identifiers

DOI

10.1002/CHIR.20753

1 reference

18 December 2017

PubMed ID

19575464

1 reference

18 December 2017